soraprazan has been researched along with Macular Degeneration in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burnet, M; Guezguez, J; Illing, B; Julien-Schraermeyer, S; Schraermeyer, U; Taubitz, T; Tschulakow, A | 1 |
| Julien, S; Schraermeyer, U | 1 |
2 other study(ies) available for soraprazan and Macular Degeneration
| Article | Year |
|---|---|
Penetration, distribution, and elimination of remofuscin/soraprazan in Stargardt mouse eyes following a single intravitreal injection using pharmacokinetics and transmission electron microscopic autoradiography: Implication for the local treatment of Star
Topics: Animals; Autoradiography; Female; Imidazoles; Intravitreal Injections; Macular Degeneration; Male; Mice; Mice, Transgenic; Microscopy, Electron, Transmission; Naphthyridines; Stargardt Disease; Treatment Outcome; Tritium | 2020 |
Lipofuscin can be eliminated from the retinal pigment epithelium of monkeys.
Topics: Animals; Imidazoles; Lipofuscin; Macaca fascicularis; Macrophages; Macular Degeneration; Naphthyridines; Retinal Pigment Epithelium | 2012 |